Chemoradiation with ENI versus IFI, High-Dose Versus Standard-Dose Radiation Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of Multicenter, Phase III Clinical Trial (NROG 001-Northern Radiation Oncology Group of China)
第一作者机构:[1]Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
推荐引用方式(GB/T 7714):
Li B.,Zhang J.,Zhang K.,et al.Chemoradiation with ENI versus IFI, High-Dose Versus Standard-Dose Radiation Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of Multicenter, Phase III Clinical Trial (NROG 001-Northern Radiation Oncology Group of China)[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2019,105(1):E188-E189.doi:10.1016/j.ijrobp.2019.06.2096.
APA:
Li, B.,Zhang, J.,Zhang, K.,Li, G.,Zheng, A....&Liu, S..(2019).Chemoradiation with ENI versus IFI, High-Dose Versus Standard-Dose Radiation Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of Multicenter, Phase III Clinical Trial (NROG 001-Northern Radiation Oncology Group of China).INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,105,(1)
MLA:
Li, B.,et al."Chemoradiation with ENI versus IFI, High-Dose Versus Standard-Dose Radiation Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of Multicenter, Phase III Clinical Trial (NROG 001-Northern Radiation Oncology Group of China)".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 105..1(2019):E188-E189